Product Description

Darifenacin Hydrobromide IP 15 mg is a pharmaceutical formulation developed for the effective management of overactive bladder (OAB) and associated urinary symptoms under medical supervision. The formulation is specifically designed to help reduce urinary urgency, increased frequency of urination, urge urinary incontinence, and frequent nighttime urination, thereby improving bladder control and enhancing overall quality of life.

Overactive bladder is a common urological condition characterized by sudden and uncontrollable urges to urinate, often accompanied by frequent urination and accidental urine leakage. These symptoms can interfere with daily activities, work productivity, social interactions, travel, and sleep quality. Effective management is essential to help patients maintain confidence, comfort, and independence in their daily lives.

Darifenacin Hydrobromide belongs to a class of medicines known as antimuscarinic or anticholinergic agents. It works by selectively blocking muscarinic receptors in the bladder muscles, helping reduce involuntary bladder contractions that cause urgency and frequent urination. By relaxing the bladder muscles, the formulation increases bladder storage capacity and improves control over urinary function.

The therapeutic action of Darifenacin helps reduce episodes of urgency, frequency, and urge incontinence while supporting more predictable bladder function. Patients may experience improved urinary control, reduced interruptions during daily activities, and better sleep quality due to decreased nighttime urination.

The formulation is commonly prescribed as part of long-term management programs for overactive bladder and urinary incontinence. Consistent use under medical supervision can contribute to significant symptom improvement and enhanced patient comfort. Treatment effectiveness may vary depending on individual patient conditions and adherence to prescribed therapy.

Manufactured under stringent WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical technologies and undergoes comprehensive quality testing to ensure safety, efficacy, purity, and pharmaceutical consistency. Every batch is carefully monitored to maintain dependable therapeutic performance and high-quality healthcare standards.

Key Features

• Supports management of overactive bladder symptoms
• Helps reduce urinary urgency and frequency
• Improves bladder control and urinary function
• Supports management of urge urinary incontinence
• Helps reduce nighttime urination episodes
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards

Uses

• Overactive bladder (OAB) management
• Urinary urgency control
• Frequent urination management
• Urge urinary incontinence treatment support
• Bladder function improvement under medical supervision

How It Works

Darifenacin Hydrobromide works by blocking specific muscarinic receptors in the bladder, helping relax bladder muscles and reduce involuntary contractions. This action increases bladder capacity and improves urinary control, helping reduce urgency, frequency, and urine leakage episodes.

Possible Side Effects

Common side effects may include:

• Dry mouth
• Constipation
• Headache
• Blurred vision
• Dizziness
• Nausea
• Dry eyes

Patients should seek immediate medical attention if severe allergic reactions, difficulty urinating, severe abdominal pain, or unusual symptoms occur.

Precautions

• Use only under medical supervision
• Inform your doctor about liver disorders, urinary retention, or gastrointestinal conditions
• Avoid overdose or self-medication
• Use cautiously in elderly patients
• Inform your healthcare provider about all ongoing medications to prevent interactions

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, the formulation undergoes stringent quality control procedures and comprehensive testing to ensure safety, efficacy, purity, and dependable therapeutic performance. Each batch is evaluated according to international pharmaceutical standards to maintain consistent quality and reliable patient outcomes.